ストックスクリーナーアプリを入手
5.85
1.74%
0.10
アフターアワーズ：
5.75
-0.10
-1.71%
前日終値:
$5.75
開ける：
$5.75
24時間の取引高:
18,817
Relative Volume:
0.29
時価総額：
$121.86M
収益：
-
当期純損益:
$-28.50M
株価収益率:
-3.2271
EPS:
-1.8128
ネットキャッシュフロー:
$-25.87M
1週間 パフォーマンス:
-0.51%
1か月 パフォーマンス:
-16.55%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$5.72
$5.85
1週間の範囲:
$5.61
$6.10
52週間の値動き範囲:
$5.50
$13.39
Satellos Bioscience Inc Stock (MSLE) Company Profile
Compare MSLE vs VRTX, REGN, ARGX, ALNY, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
MSLE
Satellos Bioscience Inc
|
5.85 | 119.78M | 0 | -28.50M | -25.87M | -1.8128 |
VRTX
Vertex Pharmaceuticals Inc
|
458.99 | 114.33B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
607.93 | 64.47B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
892.26 | 54.99B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
282.72 | 38.42B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
157.77 | 34.03B | 742.00K | -1.37B | -1.07B | -7.0731 |
Satellos Bioscience Inc Stock (MSLE) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-06 | 開始されました | Leerink Partners | Outperform |
| 2026-03-11 | 開始されました | Cantor Fitzgerald | Overweight |
Satellos Bioscience Inc (MSLE) 最新ニュース
MSLE Q1 2026 Earnings: Smaller-than-Expected Loss as Positive EPS Surprise Drives Focus on Drug Development ProgressEarnings Cycle Report - newsline.com
Satellos Bioscience (MSLE) Slips 2.54% as Stock Tests Key Support Near $5.46Dividend Arbitrage - newsline.com
Why Satellos Bioscience Inc. stock is sliding today - Wealth Awesome
Satellos Bioscience Q1 2026 Earnings: Narrower-Than-Expected Loss as DMD Program AdvancesProfit Cycle Analysis - newsline.com
Why Satellos Bioscience Inc. stock is gaining today - Wealth Awesome
Satellos Bioscience Inc Company Profile & Introduction - Moomoo
Why Satellos Bioscience Inc. stock is rising today - Wealth Awesome
MSLE SEC FilingsSatellos Bioscience Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Satellos Bioscience Inc Financial Disclosures & Filings - TradingView
Insider Traders Lose US$134k As Satellos Bioscience Drops - simplywall.st
Satellos Bioscience (MSCL) Investor Relations, Earnings Summary & Outlook - Quartr
Leerink initiates Satellos Bioscience stock with Outperform rating - Investing.com
MSLE Q1 2026 Earnings: Narrower-Than-Expected Net Loss Highlights Cost Discipline Amid Pre-Revenue StatusForward EPS Estimate - newsline.com
Satellos Bioscience (MSLE) Surges 9%: Volume Spike Tests Key Resistance ZoneMESA MA - The Legal Advocate
Satellos to Participate in Upcoming Investor Conferences - Investing News Network
Satellos Bioscience to Highlight Neuromuscular Pipeline at June Investor Conferences - TipRanks
Satellos Bioscience (NASDAQ: MSLE) to present SAT-3247 program at June investor conferences - Stock Titan
Satellos Bioscience (MSLE) Surges 7% as Biotech Stock Breaks Above Key SupportBearish Pattern Stocks - newsline.com
Satellos Bioscience (MSLE) Slides 5.5% as Biotech Sector Headwinds Weigh on SentimentHidden Order - Newser
Satellos Bioscience Q1 2026 Earnings: Narrower Loss Reported, Stock Slips on Lack of Revenue Progress - Newser
Satellos Bioscience Inc. (MSLE) Q1 2026 Earnings: Narrower-Than-Expected Loss Marks Progress Amid Pre-Revenue StageCEO Earnings Statement - Newser
CCORF Initiates Satellos Bioscience(MSLE.US) With Buy Rating, Announces Target Price $13.81 - Moomoo
Satellos Bioscience Price Target Maintained With a $11.00/Share by HC Wainwright & Co. - Moomoo
Satellos Bioscience Sets June 17, 2026 Virtual Annual Shareholder Meeting - TipRanks
Virtual AGM, board elections and pay disclosure at Satellos Bioscience (NASDAQ: MSLE) - Stock Titan
Satellos Bioscience (MSLE) Stock Analysis: Flat at $7.15, What's Next 2026-05-19Overnight Profile - The Legal Advocate
MSLE Reiterated by HC Wainwright & Co. -- Price Target Maintained at $11 - GuruFocus
Satellos Bioscience (MSLE) Q1 2026 Earnings: EPS $-0.53 Beats EstimatesHigh Attention Stocks - newser.com
Satellos Bioscience (TSX:MSCL) Extends Cash Runway Confidence - Kalkine Media
H.C. Wainwright Maintains Satellos Bioscience(MSLE.US) With Buy Rating, Maintains Target Price $11 - Moomoo
We're Not Very Worried About Satellos Bioscience's (TSE:MSCL) Cash Burn Rate - Yahoo Finance
Stocks In Play - Baystreet.ca
Satellos Bioscience (MSLE) insiders report 1.14M shares, 7.35% stake - Stock Titan
Positive Developments for Satellos (MSLE) in Q1 2026 - GuruFocus
Satellos Bioscience Inc. - Baystreet.ca
Satellos Reports First Quarter 2026 Financial Results and Highlights Company Progress - Investing News Network
Satellos Bioscience : First Quarter 2026 Management’s Discussion Analysis - marketscreener.com
Satellos Bioscience Posts Wider Q1 2026 Loss but Strengthens Balance Sheet - TipRanks
Satellos Bioscience: Q1 Earnings Snapshot - marketscreener.com
Satellos Bioscience (NASDAQ: MSLE) raises $57M and advances Duchenne trials - Stock Titan
MSLE Price Today: Satellos Bioscience Inc. Stock Price, Quote & Chart | MEXC - MEXC
Qiming reports 1.725M Satellos shares; MSLE ownership disclosure - Stock Titan
Number of shareholders of Satellos Bioscience Inc. – BOATS:MSLE - TradingView
What Satellos Bioscience (MSLE) is doing that separates it from the herd (+0.13%) 2026-05-11Alpha Picks - newser.com
Why Satellos Bioscience (MSLE) could be the anchor your portfolio needs (Smart Money Flows) 2026-05-08Real-time Trade Ideas - Newser
Certain Stock Options of Satellos Bioscience Inc. are subject to a Lock-Up Agreement Ending on 7-MAY-2026. - marketscreener.com
Certain Pre-Funded Warrants of Satellos Bioscience Inc. are subject to a Lock-Up Agreement Ending on 7-MAY-2026. - marketscreener.com
Satellos Bioscience Inc expected to post a loss of 69 cents a shareEarnings Preview - TradingView
MSLE Stock Price, Quote & Chart | SATELLOS BIOSCIENCE INC (NASDAQ:MSLE) - ChartMill
Guggenheim Initiates Satellos Bioscience(MSLE.US) With Buy Rating, Announces Target Price $23 - Moomoo
Guggenheim Initiates Satellos Bioscience at Buy With CA$31.43 Price Target - Moomoo
Satellos Bioscience Inc (MSLE) 財務データ
収益
当期純利益
現金流量
EPS
2.60%
0.94%
大文字化:
|
ボリューム (24 時間):